MRI-based staging of hepatic fibrosis: Comparison of intravoxel incoherent motion diffusion-weighted imaging with magnetic resonance elastography

Journal of Magnetic Resonance Imaging

Volumn 42, Issue 1, 2015, Pages 204-210

  Ichikawa, Shintaro ^a   Motosugi, Utaroh ^a   Morisaka, Hiroyuki ^a   Sano, Katsuhiro ^a   Ichikawa, Tomoaki ^a   Enomoto, Nobuyuki ^a   Matsuda, Masanori ^a   Fujii, Hideki ^a   Onishi, Hiroshi ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

diffusion weighted imaging (DWI); hepatic fibrosis; intravoxel incoherent motion (IVIM); magnetic resonance elastography (MRE); magnetic resonance imaging (MRI)

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION COEFFICIENT; ELASTOGRAPHY; FEMALE; HEPATOBILIARY PARAMETERS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTRAVOXEL INCOHERENT MOTION DIFFUSION WEIGHTED IMAGING; LIVER BIOPSY; LIVER FIBROSIS; LIVER PERFUSION; LIVER STIFFNESS; MAGNETIC RESONANCE ELASTOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STAGING; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; DIFFUSION; DIFFUSION WEIGHTED IMAGING; EVALUATION STUDY; IMAGE ENHANCEMENT; LIVER CIRRHOSIS; MIDDLE AGED; MOTION; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; THREE DIMENSIONAL IMAGING; VERY ELDERLY; YOUNG ADULT; YOUNG MODULUS;

ADULT; AGED; AGED, 80 AND OVER; DIFFUSION; DIFFUSION MAGNETIC RESONANCE IMAGING; ELASTIC MODULUS; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MOTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84931955574     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24760     Document Type: Article

References (41)

1. Nakagawa H, Maeda S, Yoshida H, et al., Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences. Int J Cancer 2009; 125: 2264-2269.
2. Tsukuma H, Hiyama T, Tanaka S, et al., Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328: 1797-1801.
3. Standish RA, Cholongitas E, Dhillon A, Burroughs AK, Dhillon AP,. An appraisal of the histopathological assessment of liver fibrosis. Gut 2006; 55: 569-578.
4. Bravo AA, Sheth SG, Chopra S,. Liver biopsy. N Engl J Med 2001; 344: 495-500.
5. Regev A, Berho M, Jeffers LJ, et al., Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-2618.
6. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M,. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986; 161: 401-407.
7. Le Bihan D,. Intravoxel incoherent motion perfusion MR imaging: a wake-up call. Radiology 2008; 249: 748-752.
8. Taouli B, Tolia AJ, Losada M, et al., Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol 2007; 189: 799-806.
9. Lewin M, Poujol-Robert A, Boelle PY, et al., Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 2007; 46: 658-665.
10. Girometti R, Furlan A, Bazzocchi M, et al., Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients. Radiol Med 2007; 112: 394-408.
11. Luciani A, Vignaud A, Cavet M, et al., Liver cirrhosis: intravoxel incoherent motion MR imaging-pilot study. Radiology 2008; 249: 891-899.
12. Chow AM, Gao DS, Fan SJ, et al., Liver fibrosis: an intravoxel incoherent motion (IVIM) study. J Magn Reson Imaging 2012; 36: 159-167.
13. Zang Y, Jin N, Deng J, et al., Intra-voxel incoherent motion MRI in rodent model of diethylnitrosamine-induced liver fibrosis. Magn Reson Imaging 2013; 31: 1017-1021.
14. Yoon JH, Lee JM, Baek JH, et al., Evaluation of hepatic fibrosis using intravoxel incoherent motion in diffusion-weighted liver MRI. J Comput Assist Tomogr 2014; 38: 110-116.
15. Motosugi U, Ichikawa T, Sano K, et al., Magnetic resonance elastography of the liver: preliminary results and estimation of inter-rater reliability. Jpn J Radiol 2010; 28: 623-627.
16. Hines CD, Bley TA, Lindstrom MJ, Reeder SB,. Repeatability of magnetic resonance elastography for quantification of hepatic stiffness. J Magn Reson Imaging 2010; 31: 725-731.
17. Shire NJ, Yin M, Chen J, et al., Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C. J Magn Reson Imaging 2011; 34: 947-955.
18. Ichikawa S, Motosugi U, Ichikawa T, et al., Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C. Magn Reson Med Sci 2012; 11: 291-297.
19. Yin M, Talwalkar JA, Glaser KJ, et al., Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 2007; 5: 1207-1213, e2.
20. Wai CT, Greenson JK, Fontana RJ, et al., A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-526.
21. Lemke A, Stieltjes B, Schad LR, Laun FB,. Toward an optimal distribution of b values for intravoxel incoherent motion imaging. Magn Reson Imaging 2011; 29: 766-776.
22. Rouviere O, Yin M, Dresner MA, et al., MR elastography of the liver: preliminary results. Radiology 2006; 240: 440-448.
23. Manduca A, Oliphant TE, Dresner MA, et al., Magnetic resonance elastography: non-invasive mapping of tissue elasticity. Med Image Anal 2001; 5: 237-254.
24. Talwalkar JA, Yin M, Venkatesh S, et al., Feasibility of in vivo MR elastographic splenic stiffness measurements in the assessment of portal hypertension. AJR Am J Roentgenol 2009; 193: 122-127.
25. Venkatesh SK, Yin M, Glockner JF, et al., MR elastography of liver tumors: preliminary results. AJR Am J Roentgenol 2008; 190: 1534-1540.
26. DeLong ER, DeLong DM, Clarke-Pearson DL,. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845.
27. Patel J, Sigmund EE, Rusinek H, Oei M, Babb JS, Taouli B,. Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging 2010; 31: 589-600.
28. Moteki T, Horikoshi H,. Evaluation of hepatic lesions and hepatic parenchyma using diffusion-weighted echo-planar MR with three values of gradient b-factor. J Magn Reson Imaging 2006; 24: 637-645.
29. Koinuma M, Ohashi I, Hanafusa K, Shibuya H,. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging 2005; 22: 80-85.
30. Sandrasegaran K, Akisik FM, Lin C, et al., Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol 2009; 193: 1556-1560.
31. Fujimoto K, Tonan T, Azuma S, et al., Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade. Radiology 2011; 258: 739-748.
32. Wang QB, Zhu H, Liu HL, Zhang B,. Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: a meta-analysis. Hepatology 2012; 56: 239-247.
33. Moreno AH, Rousselot LM, Panke WF, Burke ML,. The rate of hepatic blood flow in normal subjects and in patients with portal hypertension. Surg Gynecol Obstet 1960; 111: 443-450.
34. Le Bihan D, Turner R,. The capillary network: a link between IVIM and classical perfusion. Magn Reson Med 1992; 27: 171-178.
35. Goshima S, Kanematsu M, Kobayashi T, et al., Staging hepatic fibrosis: computer-aided analysis of hepatic contours on gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced hepatocyte-phase magnetic resonance imaging. Hepatology 2012; 55: 328-329.
36. Watanabe H, Kanematsu M, Goshima S, et al., Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging-preliminary observations. Radiology 2011; 259: 142-150.
37. Motosugi U, Ichikawa T, Araki T,. Rules, roles, and room for discussion in gadoxetic acid-enhanced magnetic resonance liver imaging: current knowledge and future challenges. Magn Reson Med Sci 2013; 12: 161-175.
38. Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL,. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 2011; 259: 749-756.
39. Motosugi U, Ichikawa T, Niitsuma Y, Araki T,. Acoustic radiation force impulse elastography of the liver: can fat deposition in the liver affect the measurement of liver stiffness? Jpn J Radiol 2011; 29: 639-643.
40. Dyvorne HA, Galea N, Nevers T, et al., Diffusion-weighted imaging of the liver with multiple b values: effect of diffusion gradient polarity and breathing acquisition on image quality and intravoxel incoherent motion parameters-a pilot study. Radiology 2013; 266: 920-929.
41. Kakite S, Dyvorne H, Besa C, et al., Hepatocellular carcinoma: short-term reproducibility of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0T. J Magn Reson Imaging 2014 [Epub ahead of print].